Galiximab (Anti-CD28L / CD80)

Synonyms: IDEC 114; Anti-Human CD80 Recombinant Antibody

Galiximab (Anti-CD28L/CD80) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody targeting against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma. MW:145.5 KD.

Galiximab (Anti-CD28L / CD80)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Galiximab (Anti-CD28L/CD80) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody targeting against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma. MW:145.5 KD.

Product Details

CAS No. 357613-77-5
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Galiximab (Anti-CD28L / CD80) | Galiximab (Anti-CD28L / CD80) supplier | purchase Galiximab (Anti-CD28L / CD80) | Galiximab (Anti-CD28L / CD80) cost | Galiximab (Anti-CD28L / CD80) manufacturer | order Galiximab (Anti-CD28L / CD80) | Galiximab (Anti-CD28L / CD80) distributor